Withings has established a reputation for providing clinical-grade health technologies to consumers. At CES 2025, the company introduced two new products that exemplify this mission, featuring one hardware and one software solution.
The standout product is BPM Vision, a compact blood pressure monitor designed for home use, which comes with interchangeable cuffs. Priced at $130, this device accurately measures both systolic and diastolic blood pressure, enabling users to monitor and manage conditions such as hypertension effectively.
According to Withings, the device provides “clinical accuracy”, showcasing results on a large display that guides users on how to perform the test correctly at home. It also features Wi-Fi connectivity and boasts a built-in battery that lasts over a year.
In addition to offering different cuff sizes, the BPM Vision can support up to eight user profiles, allowing multiple individuals to monitor their health data on a single device. Users can access their tracking information via the Withings app. The product is anticipated to launch in the U.S. in April, pending FDA approval.
On the software front, Withings is set to release Cardio Check on Tuesday. This service aims to provide continuous heart monitoring along with access to certified cardiologists, facilitating early detection of heart issues such as atrial fibrillation (AFib).
This new offering will be available through the Withings+ subscription service, which costs $10 per month. It will be compatible with several Withings devices, including the ScanWatch, ScanWatch 2, ScanWatch Nova, ScanWatch Nova Brilliant, Body Scan scale, BPM Core, and the BeamO, announced at last year’s event.
With a subscription, users are entitled to receive up to four cardiovascular checkups annually.
Compiled by Techarena.au.
Fanpage: TechArena.au
Watch more about AI – Artificial Intelligence
